Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 14/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 14/20 | 0.46 |
| ▸ | PREP | P48147 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7285021 | 0.95 | SIGMAR1 (0.44) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL8619569 | 0.95 | SIGMAR1 (0.44) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL7286648 | 0.95 | ITGB3 (0.43) | ITGB3ITGA2BPREPSIGMAR1MAPT | |
| SCHEMBL7286805 | 0.94 | PREP (0.43) | ITGB3ITGA2BPREPSIGMAR1MAPT | |
| SCHEMBL7296887 | 0.94 | PREP (0.43) | ITGB3ITGA2BPREPSIGMAR1MAPT | |
| SCHEMBL7284719 | 0.94 | ITGB3 (0.43) | ITGB3ITGA2BPREPSIGMAR1MAPT | |
| SCHEMBL8553717 | 0.93 | ITGB3 (0.51) | ITGB3ITGA2BPREP | |
| SCHEMBL7295402 | 0.92 | MAPT (0.42) | ITGB3ITGA2BPREPSIGMAR1MAPT | |
| SCHEMBL7364263 | 0.90 | ITGB3 (0.49) | ITGB3ITGA2BPREPSIGMAR1 | |
| SCHEMBL8221099 | 0.90 | ITGB3 (0.48) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0950658-A1 | 2-Pipirazinone-1-acetic acid dihydrochloride derivative used to inhibit platelet aggregation | Takeda Chemical Industries, Ltd. (JP) | 1999-10-20 | — | — | EP | disclosed |